About Us

We are focused on preclinical research & development and are seeking development partners or licensees to bring our technology to the market.

Glysantis™  licensed its core nanotechnology from Mirexus Biotechnologies Inc., which was founded by scientists from the University of Guelph working in the lab of Professor John Dutcher.